{"id":"W3000263047","doi":"10.1016/j.jacl.2020.01.001","title":"Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Statin; Online transaction processing; Internal medicine; Ezetimibe; Atorvastatin; Cholesterol; Lipoprotein; Database","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003212802,0.001065084,0.002393759,0.0003037801,0.0006869095,0.001260471,0.0004919614,0.001598962,0.00394934],"category_scores_gemma":[0.003911433,0.0004245915,0.002192855,0.0004351261,0.0007505024,0.001273266,0.0006363419,0.002311336,0.0005289904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007095209,"about_ca_system_score_gemma":0.0008222869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006251069,"about_ca_topic_score_gemma":0.001018255,"domain_scores_codex":[0.9984179,0.0007763744,0.0001588657,0.0002712454,0.0001597742,0.0002158531],"domain_scores_gemma":[0.9976059,0.0003915785,0.0009418261,0.0002204969,0.0001608923,0.0006792529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9713112,0.003869038,0.008292794,0.0002910374,0.0009980265,0.00004770592,0.00006009919,0.0001574598,0.001055086,0.00006626495,0.0005716353,0.01327959],"study_design_scores_gemma":[0.809853,0.1166499,0.06610024,0.0001207002,0.002560036,0.0001619461,0.00009174385,0.001060968,0.001005808,0.0003140659,0.002014611,0.00006697973],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933318,0.002684688,0.0002300886,0.0003116354,0.0001316047,0.001015163,0.0008828334,0.00003085008,0.001381256],"genre_scores_gemma":[0.9944751,0.0006763028,0.0003595553,0.0006106118,0.0002707012,0.001568958,0.001135058,0.000007769668,0.0008960903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00394934,"threshold_uncertainty_score":0.01699108,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1230577307056659,"score_gpt":0.4261600842721358,"score_spread":0.3031023535664699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}